672 related articles for article (PubMed ID: 18847403)
1. Emergence and management of drug-resistant enterococcal infections.
Arias CA; Murray BE
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):637-55. PubMed ID: 18847403
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
3. Optimizing therapy for vancomycin-resistant enterococci (VRE).
Linden PK
Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; WiechuĊa B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
6. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
Scheinfeld N
J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
[TBL] [Abstract][Full Text] [Related]
7. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium.
Top J; Willems R; Blok H; de Regt M; Jalink K; Troelstra A; Goorhuis B; Bonten M
Clin Microbiol Infect; 2007 Mar; 13(3):316-9. PubMed ID: 17391388
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococcal urinary tract infections.
Heintz BH; Halilovic J; Christensen CL
Pharmacotherapy; 2010 Nov; 30(11):1136-49. PubMed ID: 20973687
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
Deshpande LM; Fritsche TR; Moet GJ; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Abb J
Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
[No Abstract] [Full Text] [Related]
13. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
[TBL] [Abstract][Full Text] [Related]
14. [Research advances in vancomycin-resistant enterococcal infections].
Zhang SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):230-2. PubMed ID: 12911021
[No Abstract] [Full Text] [Related]
15. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
16. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
Arhin FF; Seguin DL; Belley A; Moeck G
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):168-171. PubMed ID: 28733126
[TBL] [Abstract][Full Text] [Related]
17. [Infections with Van B phenotype Enterococcus faecium and E. faecalis in patients with immune deficiency during the course of hematologic neoplasms].
Kedzierska J; Wegrzyn J; Skotnicki AB; Skop A; Pawliszyn W
Med Dosw Mikrobiol; 2003; 55(1):11-24. PubMed ID: 12908410
[TBL] [Abstract][Full Text] [Related]
18. Emerging vancomycin resistance in enterococci in India.
Ghoshal U; Garg A; Tiwari DP; Ayyagari A
Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
[TBL] [Abstract][Full Text] [Related]
19. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
20. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
